Pharmaceutical Industry Information Portal

HomeNews

News

Abbvie to collaborate with Gedeon Richter in neuropsychiatric diseases

AbbVie and Gedeon Richter Plc. ('Richter') today announced a new co-development and license agreement to research, develop and commercialize novel dopamine receptor modulators for...

Japan’s Fujifilm to halt enrollment in drug Avigan® trial, targeting COVID-19 patients

A drug once hailed as Japan's biggest contribution in the global fight against COVID-19 suffered another setback, as Fujifilm Holdings Corp said it was...

New antimicrobial air filters rapidly kill SARS-CoV-2 in under 30 seconds, study shows

The antimicrobial filters are shown to kill pathogens, such as Candida albicans, Escherichia coli, and MRSA in under 15 min and to destroy SARS-CoV-2...

U.S FDA approves drug to treat early breast cancer

AstraZeneca and Merck reported today, Lynparza (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-negative...

Indian company Dr. Reddy’s will continue to operate in the Russian market

Indian pharmaceutical major Dr. Reddy's Laboratories Ltd was focused on business continuity in and around Russia, as Indian drug exporters brace for temporary disruptions...

WHO warns of falsified DESREM (Remdesivir)

The genuine manufacturer of DESREM, Mylan Laboratories Ltd, has confirmed that the products identified in this Alert are falsified. Falsified DESREM (Remdesivir) identified in...
spot_img

Expert Articles

spot_img